(Q36692008)

15 August 2017

Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass (English)

1 reference

15 August 2017

1 reference

Vogl FD

1

1 reference

15 August 2017

Frey M

series ordinal

2

1 reference

15 August 2017

Kreienberg R

series ordinal

3

1 reference

15 August 2017

Runnebaum IB

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

83

1 reference

15 August 2017

10

1 reference

15 August 2017

1338-1343

1 reference

Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Structural aspects of the p53 protein in relation to gene evolution: a second look.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Subcellular localization of accumulated p53 in ovarian cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Clinical implications of the p53 tumor-suppressor gene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

The relationship between serum p53 autoantibodies and characteristics of human breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

p53 mutations in human cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Cancer. p53, guardian of the genome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

p53 mutations and expression in ovarian cancers: correlation with overall survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Transvaginal sonography as a screening method for the detection of early ovarian cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Mechanistic insights into p53-promoted RNA-RNA annealing.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Humoral immune response against p53 protein in patients with colorectal carcinoma.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

p53 mutation is a common genetic event in ovarian carcinoma.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Antibodies against p53 are associated with poor prognosis of colorectal cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2408792

Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy-termini of the protein

4 December 2018

1 reference

12 December 2020

Expression of the p53 gene and presence of serum autoantibodies in ovarian cancer: correlation with differentiation

1 reference

12 December 2020

Preoperative serum antibodies against the p53 protein in patients with ovarian and endometrial cancer

1 reference

12 December 2020

p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer

1 reference

12 December 2020

p53 antibodies in patients with various types of cancer: assay, identification, and characterization

1 reference

12 December 2020

Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma

1 reference

12 December 2020

Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer

1 reference

12 December 2020

Laparoscopic management of adnexal masses in premenopausal and postmenopausal women

1 reference

12 December 2020

Comparison of the diagnostic accuracy of three commercially available enzyme immunoassays for anti-p53 antibodies

1 reference

12 December 2020

p53 autoantibodies in patients with primary ovarian cancer are associated with higher age, advanced stage and a higher proportion of p53-positive tumor cells

1 reference

12 December 2020

Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma

1 reference

12 December 2020

Overexpression and mutation of p53 in epithelial ovarian cancer

1 reference

12 December 2020

Production of human p53 specific monoclonal antibodies and their use in immunohistochemical studies of tumor cells

1 reference

12 December 2020

Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1446

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

11044359

1 reference